These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 9453491)

  • 1. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.
    George DK; Goldwurm S; MacDonald GA; Cowley LL; Walker NI; Ward PJ; Jazwinska EC; Powell LW
    Gastroenterology; 1998 Feb; 114(2):311-8. PubMed ID: 9453491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
    Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
    Fargion S; Mattioli M; Fracanzani AL; Sampietro M; Tavazzi D; Fociani P; Taioli E; Valenti L; Fiorelli G
    Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of the hemochromatosis gene mutation in patients with nonalcoholic steatohepatitis and correlation with degree of liver fibrosis.
    Zamin I; Mattos AA; Mattos AZ; Migon E; Bica C; Alexandre CO
    Arq Gastroenterol; 2006; 43(3):224-8. PubMed ID: 17160239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ferritin concentration predicts hepatic fibrosis better than hepatic iron concentration in human HFE-Haemochromatosis.
    Wood MJ; Crawford DHG; Wockner LF; Powell LW; Ramm GA
    Liver Int; 2017 Sep; 37(9):1382-1388. PubMed ID: 28231420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.
    Uraz S; Aygun C; Sonsuz A; Ozbay G
    Dig Dis Sci; 2005 May; 50(5):964-9. PubMed ID: 15906776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk factors of fibrosis in nonalcoholic steatohepatitis.
    Fierbinţeanu-Braticevici C; Bengus A; Neamţu M; Usvat R
    Rom J Intern Med; 2002; 40(1-4):81-8. PubMed ID: 15526543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes.
    Mariani R; Pelucchi S; Arosio C; Coletti S; Pozzi M; Paolini V; Trombini P; Piperno A
    Blood Cells Mol Dis; 2010 Mar; 44(3):159-63. PubMed ID: 20117027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic Hjv⁻/⁻ mice.
    Padda RS; Gkouvatsos K; Guido M; Mui J; Vali H; Pantopoulos K
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G251-61. PubMed ID: 25501544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
    Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
    Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Involvement and role of iron in nonalcoholic steatohepatitis].
    Cojocariu C; Trifan A; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):308-12. PubMed ID: 19294996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging.
    Olynyk JK; St Pierre TG; Britton RS; Brunt EM; Bacon BR
    Am J Gastroenterol; 2005 Apr; 100(4):837-41. PubMed ID: 15784029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease].
    Moon JH; Park SH; Oh KC; Jung JO; Shin WG; Kim JP; Kim KO; Park CH; Hahn T; Yoo KS; Kim JH; Kim DJ; Lee MS; Park CK; Jun SY
    Korean J Gastroenterol; 2006 Jun; 47(6):432-9. PubMed ID: 16809950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.
    Chin J; Powell LW; Ramm LE; Ayonrinde OT; Ramm GA; Olynyk JK
    Sci Rep; 2019 Dec; 9(1):20234. PubMed ID: 31882912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steatosis is a cofactor in liver injury in hemochromatosis.
    Powell EE; Ali A; Clouston AD; Dixon JL; Lincoln DJ; Purdie DM; Fletcher LM; Powell LW; Jonsson JR
    Gastroenterology; 2005 Dec; 129(6):1937-43. PubMed ID: 16344062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductular reaction in hereditary hemochromatosis: the link between hepatocyte senescence and fibrosis progression.
    Wood MJ; Gadd VL; Powell LW; Ramm GA; Clouston AD
    Hepatology; 2014 Mar; 59(3):848-57. PubMed ID: 24037895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of iron and copper accumulation in the pathogenesis of non-alcoholic steatohepatitis.
    Akin K; Beyler AR; Kaya M; Erden E
    Turk J Gastroenterol; 2003 Dec; 14(4):228-33. PubMed ID: 15048596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
    Press RD; Flora K; Gross C; Rabkin JM; Corless CL
    Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.